• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 20, 2021

View Archived Issues

Hanmi initiates phase II study of FLX-475 in combination with pembrolizumab in gastric cancer

Read More

Summit selects new preclinical candidate SMT-026738 for CRE infections

Read More

Neurocrine initiates phase II trial of NBI-827104 to treat essential tremor

Read More

FDA clears IND for Kinnate's RAF inhibitor KIN-2787

Read More

First-in-class small molecule PX-69 activates PLXDC2 to treat rheumatoid arthritis

Read More

Vaginal HPV16 tumor model created to develop vaccination strategy

Read More

Enrollment begins in potentially pivotal study of berubicin in adults with GBM

Read More

Roche patents TLR antagonists

Read More

ReViral presents new antivirals for RSV

Read More

Fujifilm identifies new DHODH inhibitors

Read More

Merck & Co. synthesizes new GTPase KRAS mutant inhibitors

Read More

Olfactomedin-4 as severity biomarker in bronchiectasis

Read More

Checkmate Pharmaceuticals discovers RLR agonists

Read More

Study identifies colistin resistance drug target

Read More

Keros Therapeutics KER-012 shows promise for the treatment of PAH

Read More

Phase II data for peginterferon lambda-1a in uncomplicated COVID-19

Read More

China's NMPA approves initiation of phase I/II trial of AK-117 for medium- to high-risk MDS

Read More

FDA allows IND for phase I/IIa study of PRL-02 for metastatic prostate cancer

Read More

IMB-1018972 is safe and well tolerated in phase I study

Read More

First-in-human study begins with MC-I109V for noncirrhotic HBeAg-negative chronic HBV infection

Read More

Danish Medical Agency clears initiation of phase IIa study of sepranolone for Tourette's syndrome

Read More

CARB-X grant supports Basilea's development of small-molecule inhibitors of DXR

Read More

Crescendo Biologics begins phase I study of CB-307 in advanced PSMA-positive solid tumors

Read More

PF-07258669 from Sosei and Pfizer collaboration enters clinical trials for anorexia

Read More

GammaDelta cleared to conduct phase I study of Vdelta1 gamma-delta T-cell therapy GDX-012

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • 3D heart in chest

    At CRVBC 2025: Aging is circulating in your blood

    BioWorld Science
    All kinds of substances circulate through the bloodstream. Some are beneficial, like oxygen or nutrients, and others less so, like waste products, toxins,...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe